RS

Roger A. Sabbadini

LP Lpath: 22 patents #1 of 15Top 7%
VT Vaxiion Therapeutics: 8 patents #2 of 9Top 25%
Overall (All Time): #94,511 of 4,157,543Top 3%
36
Patents All Time

Issued Patents All Time

Showing 25 most recent of 36 patents

Patent #TitleCo-InventorsDate
9670270 Minicell based delivery of biologically active compounds Neil Berkley, Mark William Surber, Robert Klepper 2017-06-06
9274129 Methods and reagents for detecting bioactive lipids William A. Garland, Genevieve Hansen 2016-03-01
9274130 Prevention and treatment of pain using antibodies to lysophosphatidic acid Rosalia MATTEO 2016-03-01
9217749 Immune-derived moieties reactive against lysophosphatidic acid William A. Garland, Genevieve Hansen 2015-12-22
9181331 Pharmaceutical compositions for binding sphingosine-1-phosphate Scott R. Pancoast, Genevieve Hansen, William A. Garland, Marina Yu SAFONOV 2015-11-10
9163091 Compositions and methods for binding lysophosphatidic acid William A. Garland, Genevieve Hansen, James Stephen SWANEY, Rosalia MATTEO, Gordon MILLS +1 more 2015-10-20
9017986 Minicell based delivery of biologically active compounds Neil Berkley, Mark William Surber, Robert Klepper 2015-04-28
8871202 Prevention and treatment of pain using antibodies to sphingosine-1-phosphate 2014-10-28
8796429 Bioactive lipid derivatives, and methods of making and using same William A. Garland, Genevieve Hansen 2014-08-05
8614103 Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions William A. Garland, Glenn L. Stoller 2013-12-24
8604172 Humanized antibody compositions and methods for binding lysophosphatidic acid William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams 2013-12-10
8524484 Immunogenic minicells and methods of use Neil Berkley, Mark William Surber, Matthew J. Giacalone 2013-09-03
8444970 Compositions and methods for treating ocular diseases and conditions William A. Garland, Glenn L. Stoller 2013-05-21
8401799 Antibody design using anti-lipid antibody crystal structures Tom HUXFORD, Jonathan Michael WOJCIAK 2013-03-19
8361465 Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents William A. Garland 2013-01-29
8222373 Humanized antibodies and compositions for binding sphingosine-1-phosphate William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams 2012-07-17
8158124 Compositions and methods for binding lysophosphatidic acid William A. Garland, Genevieve Hansen, James Stephen SWANEY 2012-04-17
8129166 Immunogenic minicells and methods of use Neil Berkley, Mark William Surber 2012-03-06
8101396 Minicells displaying antibodies or derivatives thereof and comprising biologically active compounds Neil Berkley, Mark William Surber, Robert Klepper 2012-01-24
8067549 Humanized antibodies and compositions for binding sphingosine-1-phosphate William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams 2011-11-29
8025877 Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams 2011-09-27
8026342 Compositions and methods for binding sphingosine-1-phosphate William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams 2011-09-27
7956173 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate William A. Garland, Genevieve Hansen, Steven Jones, David G. Williams 2011-06-07
7901682 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation 2011-03-08
7871815 Rhamnose-inducible expression constructs and methods Neil Berkley, Mark William Surber 2011-01-18